Evidence map›Paper›PMID 30839240›Full record

ArticleThe neuroradiology journal2019

Pipeline embolisation device with shield technology for the treatment of ruptured intracranial aneurysm.

Christopher R Pasarikovski, Ghouth Waggass, Jillian Cardinell, Peter Howard, Leodante da Costa, Victor Xd Yang

Abstract readCase Reports
In one paragraph

Article in The neuroradiology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher R Pasarikovski1 Division of Neurosurgery, University of Toronto, Canada.ORCID https://orcid.org/0000-0003-1053-7111
Ghouth Waggass2 Division of Neurosurgery, Sunnybrook Hospital, Canada.
Jillian Cardinell2 Division of Neurosurgery, Sunnybrook Hospital, Canada.
Peter Howard3 Division of Neuroradiology, Sunnybrook Health Sciences Center, Canada.
Leodante da Costa2 Division of Neurosurgery, Sunnybrook Hospital, Canada.
Victor Xd Yang1 Division of Neurosurgery, University of Toronto, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flow diverters have emerged as a safe and effective treatment option for patients with complex unruptured cerebral aneurysms. Their utilisation in patients with ruptured aneurysms poses significant challenges, most notably the need for periprocedural dual antiplatelet medication. We describe the use of the pipeline embolisation device with shield technology in an 88-year-old patient with a complex ruptured posterior communicating artery aneurysm not amenable to microsurgical clipping or coiling alone. The pipeline embolisation device with shield technology utilises a phosphorylcholine coating to decrease thrombotic risk. We describe our antithrombotic protocol and technique to decrease the risk of acute re-rupture. The case highlights the option of using a flow diversion device with antithrombotic coatings in patients with complex ruptured cerebral aneurysms not amenable to coiling or microsurgical clipping.

Indexed as

Drug-Eluting StentsAged, 80 and overAneurysm, RupturedCerebral AngiographyCoated Materials, BiocompatibleComputed Tomography AngiographyEmbolization, TherapeuticFemaleHumansIntracranial AneurysmTomography, X-Ray ComputedTreatment OutcomeCoated Materials, Biocompatibleflow diversionPipeline embolisation deviceshieldsubarachnoid haemorrhage

Identifiers

PMID30839240
PMCPMC6512202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.